Optimizing chronic transfusion therapy for survivors of hemoglobin Barts hydrops fetalis

Blood. 2016 Mar 3;127(9):1208-11. doi: 10.1182/blood-2015-10-673889. Epub 2016 Jan 5.

Authors

Ali Amid¹, Shiyi Chen², William Brien³, Melanie Kirby-Allen¹, Isaac Odame¹

Affiliations

¹ Division of Haematology/Oncology, Department of Paediatrics.
² Department of Biostatistics, and.
³ Department of Laboratory Medicine and Pathobiology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

PMID: 26732098
DOI: 10.1182/blood-2015-10-673889

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Blood Transfusion / methods*
Child
Erythropoiesis
Female
Hemoglobins, Abnormal / metabolism*
Homozygote
Humans
Hydrops Fetalis / therapy*
Male
Survivors*

Substances

Hemoglobins, Abnormal
hemoglobin Bart's